UMEM Educational Pearls

Title: Is there utility in measuring BNP in pediatric patients in the emergency room?

Category: Pediatrics

Keywords: Congestive heart failure, trouble breathing, basic natriuretic peptide (PubMed Search)

Posted: 2/19/2021 by Jenny Guyther, MD (Updated: 4/7/2025)
Click here to contact Jenny Guyther, MD

In children with known congenital heart disease, BNP measurements are higher in those patients with heart failure compared to those without heart failure.

The utility of BNP in differentiating a cardiac from pulmonary pathology in patients with respiratory distress has been studied in pediatrics. In one study involving 49 infants with respiratory distress, the patients with a final diagnosis of heart failure had a higher mean BNP concentration than those patients with other causes.  Also, there is a suggestion that the relative change in NT proBNP levels may be useful in patients with underlying pulmonary hypertension.  However, currently there is not enough literature to support the routine use of BNP or NT proBNP in acute management.

Bottom line: BNP can be useful in your patient with congenital heart disease who is decompensating and may be used in a patient where there is difficulty in differentiating a primary respiratory from cardiac etiology.

Show References



Title: Haloperidol vs. ondansetron for cannabis hyperemesis syndrome

Category: Toxicology

Keywords: Haloperidol, ondansetron, cannabis hyperemesis syndrome (PubMed Search)

Posted: 2/18/2021 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Patients with cannabis hyperemesis syndrome experience recurrent/protracted nausea/vomiting. Cases of cannabis hyperemesis syndrome may increase as cannabis use becomes more common in the United States.

A randomized control trial (triple-blind) was conducted to compare haloperidol (0.05 or 0.1 mg/kg) IV or ondansetron 8 mg IV. Primary outcome was reduction of abdominal pain and nausea from baseline (on a 10 cm visual analog scale) 2 hours after treatment.

Results

  • 33 subjected were randomized to haloperidol (n=13) and ondansetron (n=17)
  • 30 used 1.5 gm/day since 19 years of age.
  • Haloperidol was superior to ondansetron
    • 2.3 cm difference in pain and nausea
    • Less use of rescue antiemetics (31% vs. 59%)
    • Shorter time to ED departure (3.1 hours vs. 5.6 hours)

Conclusion

  • In this small trial, haloperidol (0.05 or 0.1 mg/kg IV) was superior to ondansetron (8 mg IV) in the treatment of acute cannabis associated hyperemesis  

Show References



Title: What time of day is best for exercise to achieve weight loss goals?

Category: Orthopedics

Keywords: diabetes, exercise, weight loss (PubMed Search)

Posted: 2/13/2021 by Brian Corwell, MD (Updated: 4/7/2025)
Click here to contact Brian Corwell, MD

What time of day is best for exercise to achieve weight loss goals?

 

Working out in the morning has traditionally held the edge, especially if done on an empty stomach.

Upon walking, elevated levels of cortisol and GH will aid in fat metabolism.

Switching to a morning workout may also decrease appetite throughout the day.

Morning exercise may also induce significant circadian phase?shifting effects. Patients report feeling more alert in the morning and get more tired at night. This may “force” people to get increased rest as poor sleep quality and duration has been associated with weight gain. 

Moderate intensity aerobic exercise has been shown to cause immediate mood improvement and mental productivity. These effects can last up to 12 hours and may be a simple aid to combat job stress.

However, a recent small study looked at this question with a group of men at high risk for Type 2 diabetes.

Those that exercised in the morning had better blood sugar control and lost more abdominal fat than those who exercised in the morning.

Study:  32 adult males (58 ± 7 years) at risk for or diagnosed with type 2 diabetes performed 12 weeks of supervised exercise training either:

In the morning (8.00–10.00 a.m., N = 12) OR

In the afternoon (3.00–6.00 p.m., N = 20)

Test: Graded cycling test with ECG monitoring until exhaustion

Results:  Compared to those who trained in the morning, participants who trained in the afternoon experienced superior beneficial effects of exercise training on peripheral insulin sensitivity, insulin?mediated suppression of adipose tissue lipolysis, fasting plasma glucose levels, exercise performance and fat mass.

Conclusion:  Metabolically compromised patients may benefit from shifting their exercise routine to the afternoon from the morning. Ultimately, any exercise is great in this population, but this study may be worth sharing to your patients.

 

Show References



Title: HOT-ICU

Category: Critical Care

Keywords: Oxygenation, Mechanical Ventilation, Critical Care (PubMed Search)

Posted: 2/9/2021 by Mark Sutherland, MD
Click here to contact Mark Sutherland, MD

Optimal oxygenation targets and the possible, theoretical, benefits of hyperoxygenating critically ill patients have long been points of controversy.  Multiple studies have suggested harm in pursuing aggressive hyperoxygenation amongst critical patients with various conditions ranging from myocardial infarction to sepsis to neurologic conditions.  In addition, oxygen toxicity is a known mechanism causing ARDS.

The HOT-ICU trial adds to the list of arguments against hyperoxygenation, by looking at 2928 ICU patients on high levels of supplemental oxygen and targeting a paO2 of 60 mm Hg (low oxygen group) vs paO2 of 90 mm Hg (high oxygen group).  There was no difference in mortality, or other significant difference in outcomes.

 

Bottom Line: A lower paO2 goal of 60 (correlates to an O2 sat of 90%) is noninferior to a higher paO2 goal of 90 (O2 sat of approximately 96%).  When titrating oxygen, targeting a pulse ox of 90-96% is reasonable in critically ill patients.  Be sure to include an upper limit on the sat goal, beware an O2 sat of 100%, and titrate down supplemental oxygen when the spO2 is above goal, as the paO2 may be dangerously high.

Show References



Buprenorphine is a partial opioid receptor agonist that has a higher binding affinity than pure opioid agonists. There can be unease in managing acute pain in patients sustained on buprenorphine for opioid use disorder due to many factors.

The main barriers to effective pain management in these patients are:

  1. Opioid-Induced Hyperalgesia
    1. Patients maintained on buprenorphine can have an increased sensitivity to pain.
    2. Consider using a multimodal approach that optimizes non-opioid analgesics, such as acetaminophen and nonsteroidal anti-inflammatory drugs.
  2. Opioid Tolerance
    1. Patients maintained on buprenorphine require higher doses of opioids to treat acute pain due to the decreased effectiveness of opioids over time.
    2. As in hyperalgesia, a multimodal approach can be beneficial.
    3. Higher doses of supplemental opioids will be required in these patients compared with opioid-naïve patients.
    4. Titrate supplemental opioids to effect and monitor for toxicity.
  3. Opioid Withdrawal
    1. Opioid withdrawal symptoms can contribute to stress and anxiety, increasing pain sensitivity.
    2. To prevent withdrawal symptoms it is appropriate to continue buprenorphine throughout the episode of acute pain.
    3. The patient's typical home dose of buprenorphine can be utilized.

 

Take Home Points
In general, the treatment strategy for acute pain in patients on buprenorphine should be:

  • Optimize non-opioid analgesia.
  • Use supplemental opioids when needed.
    • Will likely require higher doses.
    • Titrate to effect.
    • Monitor for toxicity.
  • Continue buprenorphine therapy at home dose throughout the acute pain episode.

Show References



Mechanical Ventilation in COPD

  • Mechanical ventilation of the patient with obstructive lung disease can be challenging, primarily due to the presence of dynamic hyperinflation.
  • In the initial phase of ventilation, it is important to prevent complications of hyperinflation and not to target normalization of blood gas values.
  • Recommended initial ventilator settings include:
    • Mode: Volume assist-control
    • Inspiratory flow waveform: square
    • Tidal volume: 6-8 ml/kg PBW
    • RR: 12 bpm
    • Inspiratory flow: 60-90 L/min
  • The effect of PEEP is variable with each patient.  When titrating PEEP, be sure to frequently measure plateau pressure and discontinue titration should Pplat increase.

Show References



Title: Does My Seizure Patient Need An EEG?

Category: Neurology

Keywords: seizure, status epilepticus, nonconvulsive, electrographic, EEG (PubMed Search)

Posted: 1/27/2021 by WanTsu Wendy Chang, MD (Updated: 4/7/2025)
Click here to contact WanTsu Wendy Chang, MD

  • Most seizures resolve spontaneously, however, seizures that persist >5 minutes or recur without the patient returning to their baseline should be treated expeditiously with benzodiazepines and antiepileptic medications.
  • A subset of patients may continue to have electrographic seizures despite cessation of their convulsive seizure activity.
    • Prior studies described 26-52% of patients develop nonconvulsive seizures after resolution of convulsive status epilepticus.
  • The recent Established Status Epilepticus Treatment Trial (ESETT) compared fosphenytoin, levetiracetam, and valproic acid in aborting seizures and improving responsiveness in patients who did not response to initial treatment with benzodiazepines.
    • EEG was not required for this trial, but 58% (278/478) had an EEG within 24 hours after seizure onset.
      • Of those who had an EEG, 14% (39/278) had electrographic seizures.
    • For patients who had clinical treatment success, 13% (13/102) were found to have electrographic seizures.

Bottom Line: Persistent or recurrent seizures are not uncommon in the first 24 hours after status epilepticus even in patients with resolved clinical seizure activity. Early use of EEG can help identify patients who need further escalation of treatment.

 

Show References



Title: Exercise and Covid-19

Category: Airway Management

Keywords: Myocarditis, Covid-19 (PubMed Search)

Posted: 1/23/2021 by Brian Corwell, MD (Updated: 4/7/2025)
Click here to contact Brian Corwell, MD

Exercise and Covid-19

The majority of COVID-19 cases fall into the mild-to-moderate category, with symptoms lasting less than 6 weeks on average.

The disease presents a challenge for clinicians seeking to offer counsel for patients wishing to return to exercise.

A recent cohort study in Germany looked at 100 patients (avg. age 49, 53% male) who had recovered from Covid-19 infection.

Most had been healthy, with no pre-existing medical conditions, before becoming infected. 

The group had cardiac MRI (CMR) performed.

Average time interval between Covid-19 diagnosis and CMR was 71 days.

Cardiac involvement was seen in 78% of patients and ongoing myocardial inflammation in 60%.

Evidence based return to activity guidelines being developed are more conservative than in the past with other viral infections

https://link.springer.com/article/10.1007/s11420-020-09777-1/tables/1

 

 

Show References



Title: Is the anion gap metabolic acidosis due to alcoholic ketoacidosis or toxic alcohol ingestion?

Category: Toxicology

Keywords: alcoholic ketoacidosis, toxic alcohol ingestion, anion gap metabolic acidosis (PubMed Search)

Posted: 1/21/2021 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Anion gap metabolic acidosis is often found in ED patients. It can be difficult to distinguish between toxic alcohol (TA) ingestion and alcoholic ketoacidosis (AKA).  A retrospective study attempted to identify risk factors associated with AKA when TA ingestion was the alternative diagnosis.

 

New York City poison center data was reviewed from Jan 1, 2000 to April 30, 2019.

Case definition of AKA included

  1. Documented alcohol use disorder
  2. Urine or serum ketones or elevated blood beta-hydroxybutyrate concentration
  3. Anion gap >=14 mmol/L

Case definition of TA ingestion

  1. Detectable methanol or ethylene glycol concentration

Results

  • 699 patients were screened.
  • AKA diagnosis: 86
  • TA ingestion: 36

Univariate analysis showed following variables to be associated with AKA diagnosis

  • Ethanol level: OR 1.007 (95% CI: 1.001 – 1.013)
  • Anion gap: OR 1.063 (95% CI: 1.007-1.122)
  • Age (years): OR 1.036 (95% CI: 1.005 – 1.068)

Multivariate logistic regression showed elevated ethanol concentration was associated with increased odd of AKA diagnosis 

Conclusion

  • In this retrospective study, the odd of AKA diagnosis increased as ethanol concentration increased.
  • TA ingestion remains challenging diagonsis without the availability of obtaining real time TA concentration.


Title: Mammalian meat allergy (alpha-gal syndrome) following tick bites

Author: Dan Gingold, MD, MPH

Development of IgE antibodies to the oligosaccharide galactose-alpha-1-3-galactose (alpha-gal) appears to be responsible for an acquired allergy to non-primate mammalian meat (i.e., beef and pork) and derived productsAntigen in the salivary apparatus of certain ticks (gross!!) can sensitize an IgE-mediated response to alpha-gal which is present in mammalian meat. 

 
Symptoms are similar to other IgE-mediated hypersensitivity reactions, and can cause a delayed-onset reaction with hives, GI upset, or anaphylaxis after ingestion of red meat. Treatment with standard anti-histamines and epinephrine is effectiveIndividuals with no prior history of meat sensitivity can develop the syndrome at any age, often after exposure to the outdoors in tick-endemic areasSkin and blood allergy testing can confirm the diagnosis. Symptoms can persist for years, but can recede over time if not exposed to further tick bites.

 
In the US, the primary tick responsible is Lone Star Tick (Amblyomma americanum), found primarily in the Eastern, Southeastern, and Midwestern US. Other tick species in Europe, Australia, and Asia have been found to induce the syndrome as well. Interestingly, there is a cross-reactivity with the monoclonal antibody Cetuximab (used to treat colorectal and head and neck cancers), an allergic reaction to which can also induce similar alpha-gal meat sensitivity.

Having first been described in 2009, the syndrome often goes unrecognized; increased physician awareness can inform the evaluation, diagnosis, and education of patients presenting to the ED with undifferentiated allergic reaction.

 
 

 

Show References



 

Show References



Title: Lactate use in pediatric sepsis

Category: Pediatrics

Keywords: Infection, sepsis, lactic acid (PubMed Search)

Posted: 1/15/2021 by Jenny Guyther, MD (Updated: 4/7/2025)
Click here to contact Jenny Guyther, MD

Despite a lack of formal guidelines and evidence, lactate measurement has become a component of many pediatric emergency sepsis quality programs, with one survey showing that up to 68% of responding pediatric emergency medicine providers routinely measured it.

The Surviving Sepsis Campaign, last updated in February 2020, could not make a recommendation on the use of lactate in pediatric patients with suspected shock. The authors did state that lactate levels are often measured during the evaluation of septic shock if the lab can be obtained rapidly. However, lactate levels alone would not be an appropriate screening test.

Show References



Title: Do All Post-tPA Patients Require ICU Care?

Category: Neurology

Keywords: stroke, thrombolysis, tissue plasminogen activator, tPA, monitoring (PubMed Search)

Posted: 1/13/2021 by WanTsu Wendy Chang, MD
Click here to contact WanTsu Wendy Chang, MD

  • Acute ischemic stroke patients are commonly admitted to an ICU after receiving IV tPA to be closely monitored for potential complications.
  • Current post-tPA protocol requires frequent vital signs and neurological assessments up to every 15 minutes, thereby requiring 1:1 or 1:2 nurse-to-patient ratio.
  • Studies have shown that stroke severity is a strong predictor of the need for critical care interventions for post-tPA patients, where patients with an NIHSS score ≥10 have an ~8x higher odds of requiring critical care interventions than those with NIHSS <10.
  • A low-intensity post-tPA monitoring protocol (Figure 1) for patients with NIHSS <10 and no critical care needs has been found to be safe in a small single center study.
    • These low risk patients were admitted with telemetry monitoring and 1:3 nurse-to-patient ratio after an initial period of q15 min standard monitoring.
    • An international, multicenter, randomized controlled trial is being planned to study this further.

  • This strategy may help streamline care and utilize hospital resources more efficiently in the COVID-19 pandemic and beyond.

Bottom Line: Patients with NIHSS <10 may be safe for low-intensity post-tPA monitoring if they do not require critical care after an initial period of q15 min standard monitoring for the first 2 hours.

Show References



A single center (Nebraska, USA), retrospective analysis investigated the prevalence of intubation during hospital stay for 105 patients who had COVID-19 between March 24 to May 5, 2020 (1).   40 patients underwent awake proning vs. 60 patients did not undergo awake proning.

After adjusting for either SOFA or APACHE scores, patients with awake proning were associated with lower Hazard Ratios of intubation for SOFA (HR 0.30, 95% CI 0.09-0.96, p=0.043) and APACHE (HR 0.30, 95%CI 0.1-0.91, p=0.034).

 

 

Discussion

While this US study seemed promising, another Brazilian study being published earlier in July 2020 showed no difference in the prevalence of intubation between COVID-19 patients with proning or without proning (2).

These 2 studies highlighted the nature of this disease: high practice variability, uncertainty of therapeutic modalities.  However, the complications from awake proning had been very low.

Conclusion:

Awake proning for hypoxic COVID-19 patients is a promising intervention but we will need more studies.  In the meanwhile, we can try this therapeutic modality as the risk is low.

Show References



A recent retrospective observational study looked at the association of oral antibiotics (primarily fluroquinolones) and tendon rupture.

Outcome data is very interesting for our practice, deviates from traditional teaching.

Population:  1 million Medicare fee for service beneficiaries from 2007-2016 (>65 years old)

Antibiotics queried:  Seven total oral antibiotics of mixed class:

  1. Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin)
  2. Other:  Amoxicillin, amoxicillin-clavulanate, azithromycin and cephalexin.

 

Outcome measures:  all combined tendon ruptures and 3 by anatomic site (Achilles, rotator cuff {RC} and other)

Results:  Of the 3 quinolones, only LEVOfloxacin showed a significant increase in risk of tendon rupture (16% for RC) and (120% for Achilles) in a 1 month window. The others did not show an increased risk

Among the other antibiotics, cephalexin showed an increase risk across all anatomic sites.

The authors note that the risk with levofloxacin never exceeded the risk of cephalexin in any comparison!

 

 

 

Show References



Study Question: What is the association of relative hypotension (degree and duration of MPP deficit) in patients with vasopressor-dependent shock with the incidence of new significant AKI and major adverse kidney events (MAKE)? 

  • Mean Perfusion Pressure (MPP) = MAP - CVP
  • MAKE-14: composite measure of death, new initiation of RRT, or doubling of serum creatinine from the premorbid level at Day 14
  • Basal MPP estimated using pre-illness BP readings in the chart, basal CVP estimated using prior echo findings or estimated mean values

Methods:

  • Multicenter, prospective observational cohort study with 302 patients
  • Notable exclusion criteria:
    • age < 40, trauma as primary reason for ICU admission, active bleeding, unavailability of at least two preillness BP readings, pregnancy, "any condition specifically requiring a higher or a lower blood pressure target in the view of a treating clinician"

Results:

  • for every percentage increase in the time-weighted average MPP deficit, the odds of developing new significant AKI and MAKE-14 increased by 5.6% (95% CI, 2.2–9.1; P = 0.001) and 5.9% (95% CI, 2.2–9.8; P = 0.002), respectively.
  • Relationships between the risks of developing new significant AKI or MAKE-14 and the percentage of time spent with a MAP < 65 mm Hg were not statistically significant 

Take-aways:

  • Critically ill patients in shock who had higher and longer degrees of relative hypotension compared to their baseline BPs had a higher incidence of adverse kidney outcomes
  • Sidenote: also consider venous congestion/volume overload when thinking about end-organ damage (e.g. MPP not just MAP)

Show References



Title: Octreotide Shortage: Vasopressin for Variceal Bleeding

Category: Pharmacology & Therapeutics

Keywords: Octreotide, Vasopressin, Variceal Bleeding (PubMed Search)

Posted: 1/2/2021 by Wesley Oliver
Click here to contact Wesley Oliver

With a national shortage of octreotide an alternative treatment plan had to be implemented at our institution for patients presenting with variceal bleeding.

 

Drug references recommend a continuous infusion of vasopressin at 0.2 to 0.4 units/minute. Dose may be titrated as needed to a maximum dose of 0.8 units/minute with maximum duration of 24 hours to reduce incidence of adverse effects. Administer IV nitroglycerin concurrently to prevent ischemic complications and monitor closely for signs/symptoms of myocardial, peripheral, and bowel ischemia.

 

Protocol at our institution:

Vasopressin

  • Initiate vasopressin at 0.2 units/min.

  • Increase by 0.2 units/min if bleeding is not controlled after one hour (max dose: 0.8 units/min).

  • If bleeding controlled for 2 hours, can decrease by 0.2 units/min and reassess.

  • Limit use to 24 hours.

Nitroglycerin

  • Use nitroglycerin infusion to prevent adverse effects from vasopressin.

  • Initiate nitroglycerin at 40 mcg/min, titrate by 40 mcg/min to a max dose of 400 mcg/min.

  • Goal systolic blood press pressure of 90-100 mmHg.  Do not start nitroglycerin if SBP <90 mmHg.

***Please note the vasopressin dose for this indication is significantly higher than the typical dose of 0.03 units/min we use for shock.***

 

Show References



Title: TABLE: Persistently elevated serum insulin levels

Category: Toxicology

Keywords: Serum insulin level table (Attachment) (PubMed Search)

Posted: 12/31/2020 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Please see attachment for the table of serum insulin levels

Show References

Attachments



 

High dose insulin (HDI) therapy is commonly used in patients with severe beta-adrenergic antagonist and calcium channel antagonist overdose. Hypoglycemia and hypokalemia are commonly known complication of HDI therapy. However, kinetics of insulin in patients who received HDI therapy is unknown.

A 51 year-old man with amlodipine overdose was infused HDI (10 unit/kg/hr) for 37 hours; Serial serum insulin levels were drawn after discontinuation of HDI.

Serum insulin levels are shown in below table

Table    Description automatically generated

The serum insulin level remained significantly elevated during the first 24 hours (normal range: 2.6-24.9 microU/mL) and gradually decreased over 6 days.

Conclusion

  • The supraphysiologic insulin levels persist after discontinuation of HDI where patient may continue to experience hypoglycemia
  • These elevated insulin level may allow for more rapid titration or simply discontinue HDI when hemodynamic stability is achieved.

Show References

Attachments



Title: Chief complaint: "My hip snaps when I exercise"

Category: Orthopedics

Keywords: Hip pain, snapping hip, tendon (PubMed Search)

Posted: 12/27/2020 by Brian Corwell, MD (Updated: 4/7/2025)
Click here to contact Brian Corwell, MD

Chief complaint:  “My hip snaps when I exercise”

Both athletes and non-athletes may report a “snapping” sound with certain movements

This may affect up to 10% of the population

May be associated with activities than involve repetitive hip flexion

Symptoms may be due to an internal or an external cause

External causes are usually due to a tendon passing over a bony prominence

This can be felt as either an audible sensation and/or even a palpable snap

This may or may not involve pain or discomfort

This is most commonly due to a benign cause

During movements in flexion, extension or combined with internal rotation the iliotibial band may move over the greater trochanter.

Alternatively, the hamstring tendon may pass over the ischial tuberosity

There are several other causes with similar mechanisms

Symptoms are usually minimal and not serious

This can be reproduced on bedside clinical exam

               Ask the patient to identify the area of snapping with one finger which will help with anatomic localization

First line therapy is physical therapy which focuses on:

Improving muscle length if muscle is too tight   OR

Improving neuromuscular activation if problem is due to excessive muscle activation